Clinically important meperidine toxicities

Journal of Pharmaceutical Care in Pain and Symptom Control

Volumn 9, Issue 3, 2001, Pages 37-55

  Chalverus, C A ^a  

^a PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

Adverse drug reaction; Cardiac; Constipation; Delirium; Delivery; Hallucinations; Histamine; Interactions; Labor; Meperidine; Myoclonus; Neonate; Neurotoxicity; Normeperidine; Opioids; Parkinsonism; Pharmacokinetics; Respiratory; Rigors; Seizure; Seizures; Shivering; Spasmogenicity; Sphincter of oddi; Toxicity; Urinary

Indexed keywords

CODEINE; HYDROMORPHONE; LEVORPHANOL; METHADONE; MORPHINE; NORPETHIDINE; OPIATE; PETHIDINE;

ANALGESIA; BRADYCARDIA; CONSTIPATION; DELIRIUM; DRUG HALF LIFE; DRUG METABOLISM; HALLUCINATION; HISTAMINE RELEASE; HUMAN; MUSCLE SPASM; MYOCLONUS; NEUROTOXICITY; PARKINSONISM; RESPIRATION DEPRESSION; REVIEW; RIGOR; SEIZURE; URINE RETENTION;

EID: 0035178197     PISSN: 10564950     EISSN: None     Source Type: Journal    
DOI: 10.1300/J088v09n03_04     Document Type: Review

References (71)

1. Pethidine for painful crisis in sickle cell disease
2. Meperidine: Therapeutic use and toxicity
3. Practice guidelines for cancer pain management a report by the American Society of Anesthesiologists Task Force on Pain Management, Cancer Pain Section
4. Opioid analgesics and antagonists
5. Opioid analgesic drugs in the elderly
6. Naloxone, meperidine and shivering
7. Narcotic analgesic facts
8. Pain management
9. Successful treatment of normeperidine neurotoxicity by hemodialysis
10. Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure or cancer
11. Adverse effects of systemic opioid analgesics
12. Histamine release by four narcotics: A double-blind study in humans
13. Effect of delivery room routines on the success of first breast-feed
14. Exogenous opioids in human breast milk and acute neonatal neurobehavior: A preliminary study
15. Effects of morphine on the human sphincter of Oddi
16. Opioids at the sphincter of Oddi
17. Effect of modern analgesic drugs (tramadol, pentazocine, and buprenorphine) on the bile duct sphincter in man
18. Effects on biliary tract pressure in humans of intravenous ketorolac tromethamine compared with morphine and placebo
19. Adverse effects of opioid agonists and agonist-antagonists in anaesthesia
20. Jimsonweed toxicity: Management of anticholincergic plant ingestion
21. The treatment of postanaesthetic shivering: A double blind comparison between alfentanil and pethidine
22. Effect of pethidine, fentanyl and morphine on postoperative shivering in man
23. Meperidine for the treatment of shaking chills and fever
24. Meperidine for prevention of amphotericin B-induced chills
25. Efficacy of nefopam for the prevention and treatment of amphotericin B-induced shivering
26. Butorphanol tatrate (Stadol) relieves postanesthetic shaking more effectively than meperidine (Demerol) or morphine
27. Butorphanol for the relief of shivering associated with extradural anesthesia in patients
28. Neurotoxicity of meperidine
29. Neuroexcitatory effects of morphine and hydromorphone: Evidence implicating the 3-glucuronide metabolites
30. Myoclonus associated with treatment with high doses of morphine: The role of supplemental drugs
31. Putative role of hydromorphone metabolites in myoclonus
32. Grand-mal seizures associated with high-dose intravenous morphine infusions: Incidence and possible etiology
33. Seizures associated with high-dose intravenous morphine containing sodium bisulfite preservative
34. Opioid use in cancer pain. Is a more liberal approach enhancing toxicity?
35. Myoclonus associated with treatment with high doses of morphine: The role of supplemental drugs
36. Myoclonic spasms after epidural diamorphine infusion
37. Myoclonic spasms following intrathecal morphine
38. Myoclonic seizure activity with chronic high-dose spinal opioid administration
39. An apparent seizure following inadvertent intrathecal morphine
40. Complications of spinal opioid therapy: Myoclonus, spastic muscle tone and spinal jerking
41. The clinical pharmacology of meperidine
42. Meperidine-related seizures associated with patient controlled analgesia pumps
43. Meperidine-associated myoclonus and seizers in long-term hemodialysis patients
44. Central nervous system excitatory effects of meperidine in cancer patients
45. Toxicity of norpethidine in sickle cell crisis
46. Meperidine-induced seizure in a sickle cell patient using a patient controlled analgesia pump
47. Norpethidine induced myoclonus in a patient with renal failure
48. Meperidine-induced seizures in sickle cell patients
49. Norpethidine toxicity and patient controlled analgesia
50. Meperidine-associated seizures in a child
51. Meperidine-induced generalized seizures with normal renal function
52. Hazards of high-dose meperidine
53. Meperidine-induced seizure in a patient without renal dysfunction or sickle cell anemia
54. Meperidine-induced delirium
55. Psychiatric presentation of meperidine toxicity
56. Fentanyl associated delirium in man
57. Organic hallucinosis in patients receiving high doses of opiates for cancer pain
58. Opioids: Overview on action, interaction and toxicity
59. Opioid rotation for cancer pain: Rationale and clinical aspects
60. Reversible parkinsonism related to meperidine
61. Meperidine and reversible parkinsonism
62. Drug-induced parkinsonism and other movement disorders
63. The serotonin syndrome: Implicated drugs, pathophysiology and management
64. Meperidine as a potential cause of serotonin syndrome in the emergency department